#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Imaging methods in the diagnosis and treatment of pancreatic cancer


Authors: D. Girsa 1,2;  J. Weichet 1
Authors‘ workplace: Klinika radiologie a nukleární medicíny 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské, Vinohrady Praha, Česká republika 1;  2. lékařská fakulta Univerzity Karlovy, Praha, Česká republika 2
Published in: Rozhl. Chir., 2024, roč. 103, č. 4, s. 117-121.
Category: Review
doi: https://doi.org/10.33699/PIS.2024.103.4.117–121

Overview

Surgery is the only potentially curative treatment of pancreatic cancer. Imaging methods, especially computed tomography (CT), play an essential role in the detection and staging of pancreatic cancer. The primary CT finding determines the treatment strategy, namely the resectability of the cancer with a potentially curative outcome. Imaging (CT) assessments are important also throughout oncological treatment of the patients and after the surgery, as well. Our paper summarizes the current state of the art of computed tomography and magnetic resonance imaging in pancreatic cancer, including a structured CT report proposal in pancreatic cancer.

Keywords:

computed tomography – Pancreatic cancer – magnetic resonance imaging


Sources
  1. Česká onkologická společnost České lékařské společnosti J. E. Purkyně – webové stránky linkos.cz. Available at: https://www. linkos.cz/pacient-a-rodina/onkologickediagnozy/nadory-slinivky-brisni-c25/vyskyt-nadoru-slinivky-v-cr/.
  2. Krejčí D, Mužík J, Dušek L. Statistické ročenky ÚZIS: Novotvary 2019–2021 ČR − Současné epidemiologické trendy novotvarů v České republice. Available at: https://www.uzis.cz/res/f/008447/novo- tvary2019-2021.pdf.
  3. Takahashi C, Shridhar R, Huston J, et al. Correlation of tumor size and survival in pancreatic cancer. J Gastrointest Oncol. 2018 Oct;9(5):910−921. doi:10.21037/jgo.2018.08.06.
  4. Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v56−v68. doi:10.1093/annonc/ mdv295.
  5. Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987−1002. doi:10.1016/j.annonc.2023.08.009.
  6. Tempero MA, et al. National comprehensive cancer network (NCCN) clinical practice guidelines in oncology. Pancreatic adenocarcinoma version 1.2024 – December 13, 2023, Available at: https:// www.nccn.org/professionals/physician_ gls/pdf/pancreatic.pdf.
  7. Walters DM, Lapar DJ, deLange EE, et al. Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2011. doi:10.1245/s10434-011-1693-4.
  8. Zins M, Matos C, Cassinotto C. Pancreatic adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy. Radiology 2018, May;287(2):374−390. doi:10.1148/radiol.2018171670.
  9. George E, Wortman JR, Fulwadhva UP, et at. Dual energy CT applications in pancreatic pathologies. Br J Radiol. 2017 Dec;90(1080):20170411. doi:10.1259/bjr. 20170411,
  10. Hong SB, Choi SH, Kim KW, et al. Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. J Magn Reson Imaging 2019;51:1737−1744. doi:10.1002/jmri.26969.
  11. Wang L, Dong P, Wang WG, et al. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017:46:119−125. doi:10.1016/j.ijsu.2017.09.003.
  12. Joo I, Lee JM, Lee ES, et al. Preoperative CT classification of resectability of pancreatic cancer: Interobserver greement. Radiology 2019 Nov;293(2):343−349. doi:10.1148/radiol.2019190422.
  13. Katz MH, Fleming JB, Bhosale P, et al. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 2012 Dec 1;118(23):5749−5756. doi:10.1002/cncr.27636.
  14. Cassinotto C, Cortade J, Belleannée G, et al. An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment. Eur J Radiol. 2013 Apr;82(4):589−593. doi:10.1016/j. ejrad.2012.12.002.

MUDr. David Girsa
Klinika radiologie a nukleární medicíny
3. LF UK a FNKV
Šrobárova 1 150/50
100 34 Praha 10
e-mail:
david.girsa@fnkv.cz

Labels
Surgery Orthopaedics Trauma surgery
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#